KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$3.38
+2.42%
Mkt Cap $65.65M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
Implied Upside
+432.5%
Consensus $18.00 vs current $3.38
NASDAQ·Healthcare·Biotechnology
$3.38
+2.42%
Mkt Cap $65.65M
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
+432.5%
Consensus $18.00 vs current $3.38